Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Inmaculada Ales Diaz"'
Autor:
Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, Maria Ochoa-de-Olza, Sandip Pravin Patel, Scott Antonia, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T. Estrem, Jiangang Liu, Emin Avsar, Wen Hong Lin, Karim A. Benhadji, Leena Gandhi, Susan C. Guba, Inmaculada Ales Diaz
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background In this phase Ib/II open-label study, tumor immune suppression was targeted in patients with advanced refractory solid tumors and patients with recurrent/refractory non-small cell lung cancer (NSCLC) using galunisertib with nivolu
Externí odkaz:
https://doaj.org/article/f152b1db103e441ba5117026cc7aba88
Autor:
Sara Martínez Breijo, Luis M. Antón Aparicio, Carlos Méndez Méndez, Venancio Chantada Abal, Manuel Ramos Vazquez, Arturo Candal Gomez, Inmaculada Ales Diaz, Sonia Aranzazu Garcia, Lorena Paris, Raquel Losada, Ana Medina, Alfonso Mariño, David Olmos, José Luis Fernández, Cristina Azpitarte
Publikováno v:
Journal of Clinical Oncology. 32:e16091-e16091
e16091 Background: The prostate cancer associated gene 3(PCA3) is a promising and specific prostate cancer (PCa) biomarker. PCA3 can be detected in a urine sample becoming an easy and affordable te...
Autor:
Joaquina Martínez-Galán, Fernando Rivera, Javier Gallego Plazas, Antonio Irigoyen, Roberto A. Pazo Cid, Manuel Benavides, Aleydis Pisa, Sara Arevalo, A. Saenz, Inmaculada Ales Diaz, Antonieta Salud Salvia, Carmen Guillen, Enrique Aranda, Ruth Vera, T. García, E. Falcó, Vega Iranzo, Jose Luis Manzano, Marta Martin-Richard, G. Pulido
Publikováno v:
Journal of Clinical Oncology. 32:4122-4122
4122 Background: G and E have shown a survival benefit in the 1st-line setting in mPC. The aim of this study was to assess whether combining C with G+E was safe and effective as compared with G-E i...
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.